Wall Street Zen initiated coverage on shares of Milestone Scientific (NYSE:MLSS - Free Report) in a research note issued to investors on Sunday morning. The firm issued a hold rating on the stock.
Milestone Scientific Price Performance
Shares of NYSE MLSS traded up $0.03 during mid-day trading on Friday, hitting $1.00. 46,009 shares of the company's stock traded hands, compared to its average volume of 128,816. The company's 50-day moving average is $0.96 and its two-hundred day moving average is $0.98. The company has a market capitalization of $78.08 million, a P/E ratio of -14.21 and a beta of 0.93. Milestone Scientific has a 1 year low of $0.58 and a 1 year high of $1.39.
Institutional Trading of Milestone Scientific
Several hedge funds have recently made changes to their positions in the business. XTX Topco Ltd raised its position in shares of Milestone Scientific by 99.2% during the 1st quarter. XTX Topco Ltd now owns 34,135 shares of the company's stock valued at $32,000 after buying an additional 17,002 shares in the last quarter. Carnegie Investment Counsel raised its position in shares of Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company's stock valued at $166,000 after buying an additional 27,412 shares in the last quarter. Brookwood Investment Group LLC purchased a new stake in shares of Milestone Scientific during the 1st quarter valued at about $46,000. Finally, Renaissance Technologies LLC raised its position in shares of Milestone Scientific by 72.8% during the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock valued at $121,000 after buying an additional 53,198 shares in the last quarter. 5.79% of the stock is currently owned by hedge funds and other institutional investors.
About Milestone Scientific
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Further Reading
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
